USC Norris Oncology/Hematology - Newport Beach
Welcome,         Profile    Billing    Logout  
 2 Trials 
10 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Massopust, Kristy
NCT02717156: Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab in Solid Tumors

Recruiting
2
170
US
Computed Tomography, CAT, CAT Scan, Computerized Axial Tomography, Computerized Tomography, CT, CT SCAN, tomography, Laboratory Biomarker Analysis, Pembrolizumab, Keytruda, Lambrolizumab, MK-3475, SCH 900475, Positron Emission Tomography, Medical Imaging, Positron Emission Tomography, PET, PET SCAN, Positron Emission Tomography Scan, Positron-Emission Tomography, proton magnetic resonance spectroscopic imaging, Recombinant EphB4-HSA Fusion Protein, sEphB4-HSA
University of Southern California, National Cancer Institute (NCI)
Stage IV Bladder Urothelial Carcinoma, Prostate Cancer, Urothelial Carcinoma
11/25
11/26
KEYNOTE-E58, NCT04041310: Nous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumors

Active, not recruiting
1/2
115
Europe, Canada, US
GAd-209-FSP low dose, MVA-209-FSP low dose, GAd-209-FSP high dose, MVA-209-FSP high dose, GAd20-209-FSP, RP2D, MVA-209-FSP, RP2D, KEYTRUDA®, pembrolizumab
Nouscom SRL, Merck Sharp & Dohme LLC
Solid Tumor, Adult
04/25
11/26
NCT01802346: Controlled Low Calorie Diet in Reducing Side Effects and Increasing Response to Chemotherapy in Patients With Breast or Prostate Cancer

Active, not recruiting
N/A
130
US
dietary intervention, Dietary Modification, intervention, dietary, nutritional support, nutritional assessment, nutritional care, support, nutritional, laboratory biomarker analysis
University of Southern California, National Cancer Institute (NCI), Mayo Clinic
Breast Cancer, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer
01/25
01/26
NCT06336928: A Validation Study to Determine Concordance of Liquid Biopsy and Breast Cancer Diagnosis

Recruiting
N/A
490
US
Non-Interventional Study
University of Southern California, National Cancer Institute (NCI)
Breast Carcinoma
06/29
06/30
NCT03594448: Detection of MSI in Circulating Tumor DNA of Colorectal Carcinoma Patients

Terminated
N/A
6
US
Specimen Collection, Serial Liquid Biopsy
University of Southern California, National Cancer Institute (NCI)
Microsatellite Instability, Colorectal Cancer Stage IV
09/23
09/23
Kefauver, Cheryl
NCT02717156: Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab in Solid Tumors

Recruiting
2
170
US
Computed Tomography, CAT, CAT Scan, Computerized Axial Tomography, Computerized Tomography, CT, CT SCAN, tomography, Laboratory Biomarker Analysis, Pembrolizumab, Keytruda, Lambrolizumab, MK-3475, SCH 900475, Positron Emission Tomography, Medical Imaging, Positron Emission Tomography, PET, PET SCAN, Positron Emission Tomography Scan, Positron-Emission Tomography, proton magnetic resonance spectroscopic imaging, Recombinant EphB4-HSA Fusion Protein, sEphB4-HSA
University of Southern California, National Cancer Institute (NCI)
Stage IV Bladder Urothelial Carcinoma, Prostate Cancer, Urothelial Carcinoma
11/25
11/26
NCT03552796: sEphB4-HSA in Treating Participants With BCG-Unresponsive or Refractory Bladder Cancer

Withdrawn
2
36
US
Pharmacokinetic Study, PHARMACOKINETIC, PK Study, Recombinant EphB4-HSA Fusion Protein, sEphB4-HSA
University of Southern California, National Cancer Institute (NCI)
Recurrent Bladder Carcinoma, Bladder Cancer Stage 0, Bladder Cancer Stage I
08/24
08/25
NCT03568292: Virtual Reality in Reducing Pain and Anxiety in Cancer Participants Undergoing Painful Procedures

Recruiting
N/A
60
US
Best Practice, standard of care, standard therapy, Laboratory Biomarker Analysis, Oculus Rift Headset, Questionnaire Administration
University of Southern California, National Cancer Institute (NCI), Virtually Strong, LLC
Malignant Neoplasm
03/25
03/26
NCT06067295: Longitudinal Advanced Prostate Cancer Cohort (LAPCC)

Recruiting
N/A
150
US
Non-Interventional Study
University of Southern California, National Cancer Institute (NCI)
Prostate Carcinoma
02/26
02/27
Angstreich, Greg
NCT02717156: Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab in Solid Tumors

Recruiting
2
170
US
Computed Tomography, CAT, CAT Scan, Computerized Axial Tomography, Computerized Tomography, CT, CT SCAN, tomography, Laboratory Biomarker Analysis, Pembrolizumab, Keytruda, Lambrolizumab, MK-3475, SCH 900475, Positron Emission Tomography, Medical Imaging, Positron Emission Tomography, PET, PET SCAN, Positron Emission Tomography Scan, Positron-Emission Tomography, proton magnetic resonance spectroscopic imaging, Recombinant EphB4-HSA Fusion Protein, sEphB4-HSA
University of Southern California, National Cancer Institute (NCI)
Stage IV Bladder Urothelial Carcinoma, Prostate Cancer, Urothelial Carcinoma
11/25
11/26

Download Options